BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36891308)

  • 1. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
    Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
    Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
    Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
    Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
    Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDCA1
    Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
    Niveau C; Sosa Cuevas E; Saas P; Aspord C
    Immunology; 2024 May; ():. PubMed ID: 38742251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
    Ouaguia L; Dufeu-Duchesne T; Leroy V; Decaens T; Reiser JB; Sosa Cuevas E; Durantel D; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(12):e1208. PubMed ID: 33312564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.
    Sosa Cuevas E; Saas P; Aspord C
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
    Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
    Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
    J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.
    Makandar AI; Jain M; Yuba E; Sethi G; Gupta RK
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour glyco-code as a novel immune checkpoint for immunotherapy.
    RodrÍguez E; Schetters STT; van Kooyk Y
    Nat Rev Immunol; 2018 Mar; 18(3):204-211. PubMed ID: 29398707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
    Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
    J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
    Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2019; 10():112. PubMed ID: 30778353
    [No Abstract]   [Full Text] [Related]  

  • 15. Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80
    Sosa Cuevas E; Bendriss-Vermare N; Mouret S; De Fraipont F; Charles J; Valladeau-Guilemond J; Chaperot L; Aspord C
    Clin Transl Immunology; 2022; 11(5):e1382. PubMed ID: 35517992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes.
    Girard P; Sosa Cuevas E; Ponsard B; Mouret S; Gil H; Col E; De Fraipont F; Sturm N; Charles J; Manches O; Chaperot L; Aspord C
    Clin Transl Immunology; 2021; 10(11):e1329. PubMed ID: 34786191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.
    Rapoport EM; Khaidukov SV; Gaponov AM; Pazynina GV; Tsygankova SV; Ryzhov IM; Belyanchikov IM; Milona P; Bovin NV; McCullough KC
    Glycoconj J; 2018 Apr; 35(2):191-203. PubMed ID: 29388006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors.
    Busold S; Nagy NA; Tas SW; van Ree R; de Jong EC; Geijtenbeek TBH
    Front Immunol; 2020; 11():134. PubMed ID: 32117281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.